Many previous studies have shown that artery calcification is linked to increased bone loss. Other studies have suggested that an agent released from bone causes artery calcification by traveling through blood. Previous studies have also shown that serum has crystal formation activity, and our goal is to develop a quantitative assay for this activity. Our long term goal is to determine if serum crystal forming activity is elevated in patients with increased bone loss.
In previous studies, Erin Hourigan developed a method to monitor serum crystal formation activity by diluting serum 50 fold with 2mM Calcium and Phosphate at 37C and pH 7.4. Hourigan’s assay measured Calcium decline at multiple time-points, and was very labor intensive. In contrast, my assay allows the Calcium decline to go to completion and then directly monitors serum’s crystal formation activity by counting the number of crystals present in solution in addition to measuring Calcium decline in solution.
The number of crystals counted by our assay were significantly higher (p<.0005) in human neonates than in human adults, which may be due to the fact that the rate of bone turnover is significantly higher in newborns than in adults, causing a rise in neonate’s serum crystal formation activity. We found that crystals counted by our assay probably originate from the growth of much smaller crystals already present in serum and are not formed by a serum catalyst. This assay is the first demonstration that human serum has crystals that can be directly counted.
Throughout one’s life a person’s bone constantly goes through bone resorption and bone formation in a process called bone remodelling. Bone diseases such as osteoporosis are caused by a dysregulation of this bone remodelling. Bone resorption is well understood, but the molecular mechanism and biology of bone formation is not fully understood. It is known that osteoblasts (bone forming cells) form a 5-10 um layer of osteoid (bone matrix) and calcify (mineralize) it to form bone. However, the exact process by which osteoblasts calcify osteoid is not fully understood. In this study we show that it is possible for lamellar bone formation to occur via a two step “seed-grow” mechanism. In this mechanism osteoblasts first seed osteoid with many small mineral crystals, after which the seed crystals go on to grow and calcify osteoid to form the final bone tissue. The seed crystals grow by taking calcium and phosphate from the circulating blood that bathes osteoid and therefore do not require osteoblasts for mineral growth past the initial seeding step. The seed-grow mechanism was tested via a trabecular bone block model system, where blocks of bovine trabecular bone were decalcified (demineralized) to recreate the initial osteoid material (bone collagen blocks). Bone collagen blocks were then artificially seeded with many small crystals via a previously developed technique and incubated in adult bovine serum without osteoblasts. The bone collagen blocks recalcified (remineralized) and hardened, eventually forming a complete, freestanding mineral continuum – a characteristic of the mineral phase in normal bone.
Cookie SettingseScholarship uses cookies to ensure you have the best experience on our website. You can manage which cookies you want us to use.Our Privacy Statement includes more details on the cookies we use and how we protect your privacy.